NVS : Summary for Novartis AG - Yahoo Finance

U.S. Markets open in 15 mins.

Novartis AG (NVS)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
76.350.00 (0.00%)
At close: 4:02PM EDT

76.99 0.62 (0.81%)
Pre-Market: 9:01AM EDT

People also watch
GSKSNYAZNLLYABT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close76.35
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume2,714,440
Market Cap180.35B
Beta0.72
PE Ratio (TTM)27.27
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.72 (3.71%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Biotech And Pharma Industry And Stock News
    Investor's Business Daily47 minutes ago

    Biotech And Pharma Industry And Stock News

    Track the latest trends and leading stocks in the biotech and pharmaceutical industries.

  • Reuters19 hours ago

    U.S. top court grapples over making copycat biologics available sooner

    U.S. Supreme Court justices on Wednesday struggled over whether to speed up the time it takes to bring to the market copycat versions of biologic drugs, expensive medicines that can generate billions of dollars in sales for drug makers. The nine justices heard arguments in an appeal by Novartis AG of a lower court decision that prevented the Swiss pharmaceutical company from selling its biosimilar version of California-based Amgen Inc's $1-billion-a-year Neupogen until six months after the Food and Drug Administration approved it. The ruling in the case, due by the end of June, could determine how quickly patients have access to near-copies of biologic drugs called biosimilars at potentially cheaper prices.

  • GuruFocus.com20 hours ago

    Jerome Dodson Comments on Novartis

    Guru stock highlight